Clinical trial
Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease
NCT06580431 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease
- Lead sponsor
- Istanbul Medipol University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 21, 2023
- Completion date
- June 25, 2024
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory response, periodontitis, smoking